ConductScience.org, home

Paper37605

The beta-adrenergic blocking agents and the treatment of glaucoma.

Zimmerman TJ and 1 other. Surv Ophthalmol, 1979. Cited by 66 papers, by iCite.

Cite this record

ConductScience Library. The beta-adrenergic blocking agents and the treatment of glaucoma. Papers, record 37605. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37605

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The beta-adrenergic blocking agents and the treatment of glaucoma.
PubMed
Journal
Surv Ophthalmol
PubMed
Year
1979
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
3.77
iCite
Revised in PubMed
2019-09-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zimmerman TJT J
2Boger WP 3rdW P

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
GlaucomaMajor topic
PropanolaminesMajor topic
TimololMajor topic
Animals
Aqueous Humor
Autonomic Nervous System
Dogs
Dose-Response Relationship, Drug
Evaluation Studies as Topic
Eye
Humans
Intraocular Pressure
Rabbits
Time Factors
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
31861609Synthesis and Application of 1,2-Aminoalcohols with Neoisopulegol-Based Octahydrobenzofuran Core.Molecules2019https://conductscience.org/library/papers/31861609PubMed
31057923Towards smart self-clearing glaucoma drainage device.Microsyst Nanoeng2018https://conductscience.org/library/papers/31057923PubMed
29606703The Importance of Medicinal Chemistry Knowledge in the Clinical Pharmacist's Education.Am J Pharm Educ2018https://conductscience.org/library/papers/29606703PubMed
29343839Musical auditory stimulus acutely influences heart rate dynamic responses to medication in subjects with well-controlled hypertension.Sci Rep2018https://conductscience.org/library/papers/29343839PubMed
27916026Role of cyclic AMP in the eye with glaucoma.BMB Rep2017https://conductscience.org/library/papers/27916026PubMed
19266054Pharmacogenetics of ophthalmic topical beta-blockers.Per Med2008https://conductscience.org/library/papers/19266054PubMed
17542770Pharmacogenetics of beta-blockers.Pharmacotherapy2007https://conductscience.org/library/papers/17542770PubMed
7042481A dose-response study of oral atenolol administered once daily in patients with raised intra-ocular pressure.Graefes Arch Clin Exp Ophthalmol1982https://conductscience.org/library/papers/7042481PubMed
6351901Comparison of ocular hypotensive effects of 3 dosages of oral atenolol.Br J Ophthalmol1983https://conductscience.org/library/papers/6351901PubMed
6338906Effect of pindolol on intraocular pressure in glaucoma: pilot study and a randomised comparison with timolol.Br J Ophthalmol1983https://conductscience.org/library/papers/6338906PubMed
6293532Beta adrenergic receptors in pigmented ciliary processes.Br J Ophthalmol1982https://conductscience.org/library/papers/6293532PubMed
6261257Adrenergic regulation of intraocular pressure: identification of beta 2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6261257PubMed
6150744ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.Br J Pharmacol1984https://conductscience.org/library/papers/6150744PubMed
6116512Effects of a potent and specific beta 2-adrenoceptor antagonist on intraocular pressure.Br J Pharmacol1981https://conductscience.org/library/papers/6116512PubMed
6092239R-enantiomer of timolol: a potential selective ocular antihypertensive agent.Graefes Arch Clin Exp Ophthalmol1984https://conductscience.org/library/papers/6092239PubMed
2579877Effects of S-596 and carteolol, new beta-adrenergic blockers, and flurbiprofen on the human eye: a fluorophotometric study.Graefes Arch Clin Exp Ophthalmol1985https://conductscience.org/library/papers/2579877PubMed
1351412Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.Drugs Aging1992https://conductscience.org/library/papers/1351412PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IGKV5-228907PubTator's text mininghttps://conductscience.org/library/genes/28907NCBI Gene
MS4A1931PubTator's text mininghttps://conductscience.org/library/genes/931NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37605

GET https://conductscience.org/api/papers/v1/37605/authors